SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR-Reference-Cited by-同舟云学术

SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR

Published:1989-07 Issue:8653 Volume:334 Page:27-30
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zurlo MariaGrazia,De Stefano Piero,Borgna-Pignatti Caterina,Di Palma Annunziata,Melevendi Caterina,Piga Antonio,Di Gregorio Felicia,Burattini MariaGabriella,Terzoli Severina

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Problems related to treatment of beta-thalassemia major;Economidou;Paediatrician,1982

2. Survival and desferrioxamine in thalassaemia major;Modell;Br Med J,1982

3. Nonparametric estimations from incomplete observations;Kaplan;J Am Stat Assoc,1958

4. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples;Peto;Br J Cancer,1977

5. Statistical methods in cancer research. II. the design and analysis of cohort studies;Breslow,1987

Cited by 516 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis;Frontiers in Hematology;2024-02-05

2. Αlpha-thalassemia: A practical overview;Blood Reviews;2024-01

3. An update on recent studies of extracellular vesicles and their role in hypercoagulability in thalassemia (Review);Biomedical Reports;2023-12-28

4. Circulating microRNAs and hepcidin as predictors of iron homeostasis and anemia among school children: a biochemical and cross-sectional survey analysis;European Journal of Medical Research;2023-12-15

5. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25